HR 124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Bill status
- Status
- In committee
- Sponsor
- Rep. Al Green [D-TX-9]
- Cosponsors
- 0
- Policy area
- Health
- Introduced
- 2025-01-03
- Latest action
- 2025-01-03: Referred to the House Committee on Energy and Commerce.
Committee referrals
Recent actions
- 2025-01-03: Referred to the House Committee on Energy and Commerce.
- 2025-01-03: Introduced in House
- 2025-01-03: Introduced in House